MMR deficiency was associated with poor outcome only when p53 aberrant and polymerase-ε mutant tumors were excluded from the MMR proficient subgroup, in accordance with molecular classification based on The Cancer Genome Atlas. The gene discussed is MRC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.